Since 2023, Transmedic has partnered with AliveDx to transform autoimmune and allergy diagnostics across the region. Leveraging the MosaiQ platform, clinicians can run multiple tests from a single sample, while the LumiQ system automates immunofluorescence workflows from start to finish. Together, these technologies accelerate the detection of complex autoimmune conditions, enabling laboratories and clinical teams to make faster, more informed decisions and ultimately improve patient care.